Human Umbilical Vein Endothelial Cells Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-215960) | Inquiry | Add to cart | |
| 0.5 ml(Cat-410658) | Inquiry | Add to cart | |
| 1.5 ml(Cat-410759) | Inquiry | Add to cart | |
| 8.0 ml(Cat-410861) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 80% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
The HUVEC cell line comes from human umbilical vein endothelial cells and gets its name from its origin. Scientists believe that HUVEC cells play a vital role in angiogenesis, which is important for providing nutrients during cancerous growth. Therefore, HUVEC cells are often used in cancer research.
Moreover, HUVEC systems are frequently used in physiological and pharmacological studies, such as examining macromolecular transport, fibrinolysis, and blood coagulation. Scientists have found that when cytokines stimulate HUVEC cells, they can express cell adhesion molecules. To facilitate research, CD BioSciences has developed an advanced lipid-based HUVEC transfection kit, specially designed for umbilical vein endothelial cells.
